These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 11347053)
1. [Lipid metabolism in Cushing's syndrome]. Yoshida C; Miyachi Y Nihon Rinsho; 2001 Mar; 59 Suppl 3():177-80. PubMed ID: 11347053 [No Abstract] [Full Text] [Related]
2. [Cardiovascular diseases and lipid abnormalities in Cushing's syndrome]. Luton JP; Richard C; Laudat MH; Pinon JC; Bricaire H Nouv Presse Med; 1982 Sep; 11(36):2693-8. PubMed ID: 7145656 [TBL] [Abstract][Full Text] [Related]
3. Pathophysiology of dyslipidemia in Cushing's syndrome. Arnaldi G; Scandali VM; Trementino L; Cardinaletti M; Appolloni G; Boscaro M Neuroendocrinology; 2010; 92 Suppl 1():86-90. PubMed ID: 20829625 [TBL] [Abstract][Full Text] [Related]
4. [Secondary hyperlipidemia due to endocrine disorders]. Yoshino G; Maeda E Nihon Rinsho; 1990 Nov; 48(11):2565-71. PubMed ID: 2270022 [No Abstract] [Full Text] [Related]
5. Should we evaluate for cardiovascular disease in patients with Cushing's syndrome? Fallo F; Sonino N Clin Endocrinol (Oxf); 2009 Dec; 71(6):768-71. PubMed ID: 19508589 [TBL] [Abstract][Full Text] [Related]
6. [Indicators of lipid and carbohydrate metabolism and insulin content in glucose tolerance test in patients with Itsenko-Cushing's syndrome]. Bogatyrev OP; Tishenina RS; Zenovko EI Sov Med; 1975 Sep; (9):115-8. PubMed ID: 1231014 [No Abstract] [Full Text] [Related]
7. Cardiovascular disease in Cushing's syndrome: heart versus vasculature. De Leo M; Pivonello R; Auriemma RS; Cozzolino A; Vitale P; Simeoli C; De Martino MC; Lombardi G; Colao A Neuroendocrinology; 2010; 92 Suppl 1():50-4. PubMed ID: 20829618 [TBL] [Abstract][Full Text] [Related]
8. [Hyperlipidemia in patients with GH deficiency]. Hizuka N Nihon Rinsho; 2001 Mar; 59 Suppl 3():167-71. PubMed ID: 11347051 [No Abstract] [Full Text] [Related]
11. High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines. Mancini T; Kola B; Mantero F; Boscaro M; Arnaldi G Clin Endocrinol (Oxf); 2004 Dec; 61(6):768-77. PubMed ID: 15579193 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular consequences of cortisol excess. Whitworth JA; Williamson PM; Mangos G; Kelly JJ Vasc Health Risk Manag; 2005; 1(4):291-9. PubMed ID: 17315601 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular and renal complications of Cushing's syndrome. SCHOLZ DA; SPRAGUE RG; KERNOHAN JW N Engl J Med; 1957 May; 256(18):833-7. PubMed ID: 13451949 [No Abstract] [Full Text] [Related]
14. [Hypertension and Cushing's disease]. Luton JP; Vidal-Trecan G; Mouveroux F; Bricaire H Ann Med Interne (Paris); 1983; 134(3):203-8. PubMed ID: 6625411 [TBL] [Abstract][Full Text] [Related]
17. [Metabolism of adipose tissue in normal humans and in various metabolic disorders. II. The adipose tissue in metabolic diseases]. Sezille G; Jaillard J; Biserte G Ann Biol Clin (Paris); 1970; 28(3):209-15. PubMed ID: 5478256 [No Abstract] [Full Text] [Related]